HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
INCY
Incyte Corp
Healthcare Biotechnology · Delaware, USA · Reports in usd
Market Cap: $19.29B
Market Cap
$19.29B
Enterprise Val
$15.30B
P/E Ratio
13.47
P/B Ratio
3.43
Trailing PEG (1Y)
0.16
As Of
Apr 30, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$5.62B
Gross Margin91.79%
Profit Margin91.79%
Return on Equity29.20%
Return on Assets21.65%
Current Ratio3.68
Debt/Equity0.01
LT Debt/Equity0.01
Revenue Per Share6.39

Income Statement

Mar 31, 2026
Revenue$1.27B
Cost of Revenue$104.5M
Gross Profit$1.17B
R&D$515.9M
SG&A$328.1M
Operating Expenses$867.0M
Operating Income$301.1M
Interest Expense$569.0K
Tax Expense$40.3M
Net Income$303.3M
EPS (Basic)$1.52
EPS (Diluted)$1.47
EBIT$344.2M
EBITDA$368.0M
Consolidated Income$303.3M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$3.46B
Accounts Receivable$1.05B
Inventory$447.0M
Current Assets$5.48B
LT Investments$54.6M
Property, Plant & Equipment$746.8M
Intangibles$243.2M
Non-Current Assets$1.85B
Total Assets$7.34B
Accounts Payable$228.6M
Current Debt$4.4M
Current Liabilities$1.49B
LT Debt$29.4M
Non-Current Liabilities$226.6M
Total Liabilities$1.72B
Total Debt$33.8M
Retained Earnings$517.1M
Shareholder Equity$5.62B
Shares Outstanding199,014,486

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow$369.4M
Investing Cash Flow-$88.2M
Financing Cash Flow$84.8M
CapEx-$10.2M
Free Cash Flow$359.2M
Depreciation & Amort.$23.8M
Stock-Based Comp$64.1M
Acquisitions / Disposals$0.00
Investment Activity-$73.0M
Debt Issued/Repaid-$1.2M
Equity Issued/Repaid$97.9M
Dividends Paid$0.00
Net Change in Cash$363.3M
Data cached · Meta live · Daily live · Statements live · TTL 24h